Medical cannabis producer secures UK sales licence
Leicestershire medical cannabis producer Dalgety has now been granted both a Home Office licence and full EU-GMP certification.
The company’s 30,000 sq ft Midlands facility has secured its Good Manufacturing Practice (GMP) licence from the Medicines and Healthcare products Regulatory Agency (MHRA) after passing an inspection, which included over 600 quality control tests on various medical cannabis batches.
It allows Dalgety to cultivate, manufacture and supply EU-GMP grade high THC medicinal cannabis within the UK pharmaceutical market.
The product will be packaged and distributed through its supply partner, Grow Pharma, and will be available to patients via medical prescriptions from licensed doctors.
James Leavesley, chief executive at Dalgety, said: “This upgrade to our licence is a huge accomplishment for the Dalgety team, and more importantly, means we can deliver UK grown products to UK patients, an ambition we have been striving towards since founding the business five years ago.
“We are one of just two EU-GMP cultivators that now have this rare privilege, and with that comes a responsibility to deliver on our commitments to the UK medical cannabis community and help improve patient lives. It also showcases the strength of our business operation and what we’re capable of. We’re here, and we’re ready.”
